TK-90
- Generic Name
- TK-90
Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690
- First Posted Date
- 2023-01-03
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Tosk, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT05669521
- Locations
- 🇮🇳
Saveetha Medical college Chennai, Chennai, Tamil Nadu, India
🇮🇳Om Sai Onco Surgery Multispecialty Hospital Center, Kolhapur, Maharashtra, India
🇮🇳Jawaharlal Nehru Cancer Hospital and Research Centre, Bhopal, Madhya Pradesh, India
Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690
- First Posted Date
- 2022-12-20
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Tosk, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT05658016
- Locations
- 🇮🇳
Saveetha Medical College and Hospita, Chennai, Tamil Nadu, India
🇮🇳Apex Hospital, Varanasi, Uttar Pradesh, India
🇮🇳Netaji Subhash Chandra Bose Hospital, Kolkata, West Bengal, India
Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690
- First Posted Date
- 2019-08-06
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Tosk, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT04046250
- Locations
- 🇮🇳
Bangalore Cancer, Bangalore, Karnataka, India
🇮🇳Karnatak Cancer Therapy and Research Institute, Navanagar, Karnataka, India
🇮🇳Netaji Subhash Chandra Bose Cancer Hospital, Kolkata, West Bengal, India
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath